U.S., Oct. 21 -- ClinicalTrials.gov registry received information related to the study (NCT07217938) titled 'Novel Treatment of Radiation Associated Dysphagia With Statins' on Sept. 09.
Brief Summary: The aim of this trial is to examine the feasibility, acceptability, and potential efficacy of a 12-month course of pravastatin as an antifibrotic agent for managing dysphagia (swallowing problems) in patients previously treated with radiotherapy for head and neck cancer (HNC). The purpose is to assess whether pravastatin, a medication approved in Australia for cholesterol management, can improve swallowing in people with long-term radiation-associated dysphagia following HNC treatment.
The trial will recruit 48 patients, with an anticipated ...